Skip to main content
    V

    Vertex Pharmaceuticals Inc (VRTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $537.79
    -0.81 (-0.15%)

    Market Cap: $136.56B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Vertex Pharmaceuticals Inc (VRTX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Vertex Pharmaceuticals are Regeneron Pharmaceuticals (REGN), Moderna (MRNA) and Royalty Pharma Plc (RPRX). Vertex Pharmaceuticals trades at 30.0x earnings, against a median of 33.5x for the 5 of these companies with a P/E. By market cap, Vertex Pharmaceuticals is the largest of the 13 companies on this page, at $136.56B.

    Peer Comparison

    VRTX's ROIC of 14.2% is above the peer median of -28.9%, and its revenue growth of 11.8% is below the median of 31.5%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Vertex Pharmaceuticals (VRTX)$136.56B30.0x10.5x30.7%14.2%11.8%0.00%
    Regeneron Pharmaceuticals Inc (REGN)$98.84B18.4x5.7x28.5%13.7%36.3%0.39%
    Moderna Inc (MRNA)$90.38BN/A34.2x-110.5%-28.9%29.2%0.00%
    Royalty Pharma Plc (RPRX)$39.85B12.9x11.7x25.7%7.6%13.3%1.37%
    BeOne Medicines AG (ONC)$47.58B50.0x18.7x13.9%7.5%33.8%0.00%
    argenx NV ADR (ARGX)$60.37B33.5x6.1x31.7%N/A52.1%0.00%
    Revolution Medicines Inc (RVMD)$37.27BN/A181.6x0.0%-52.1%-95.2%0.00%
    Beam Therapeutics Inc (BEAM)$2.36BN/A15.0x-73.9%-29.7%-96.8%0.00%
    BridgeBio Pharma Inc (BBIO)$15.25BN/A16.0x-59.8%-33.0%192.6%0.00%
    Theravance Biopharma Inc (TBPH)$884.18M95.1x8.4x51.6%N/A-20.9%0.00%
    Roivant Sciences Ltd (ROIV)$28.64BN/A679.3x0.0%N/A2136.0%0.00%
    X4 Pharmaceuticals Inc (XFOR)$318.59MN/A21.7x0.0%-36.9%63.1%0.00%
    Rocket Pharmaceuticals Inc (RCKT)$256.82MN/AN/A0.0%-2.3%0.0%0.00%
    Peer median$32.95B33.5x16.0x0.0%-28.9%31.5%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Vertex Pharmaceuticals, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Regeneron Pharmaceuticals Inc (REGN)
    Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.
    REGN competitors
    Moderna Inc (MRNA)
    Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology...
    MRNA competitors
    Royalty Pharma Plc (RPRX)
    Royalty Pharma plc is a buyer of biopharmaceutical royalties and funder of innovations in the biopharmaceutical industry in the United States.
    RPRX competitors
    BeOne Medicines AG (ONC)
    BeiGene, Ltd., an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe...
    ONC competitors
    argenx NV ADR (ARGX)
    argenx SE, a clinical-phase biotechnology company, focuses on the development of antibody-based therapies for the treatment of autoimmune diseases...
    ARGX competitors
    Revolution Medicines Inc (RVMD)
    Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted...
    RVMD competitors
    Beam Therapeutics Inc (BEAM)
    Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States.
    BEAM competitors
    BridgeBio Pharma Inc (BBIO)
    BridgeBio Pharma, Inc. is dedicated to the discovery, development and supply of various drugs for genetic diseases.
    BBIO competitors
    Theravance Biopharma Inc (TBPH)
    Theravance Biopharma, Inc., a diversified biopharmaceutical company, discovers, develops, and markets organ-selective drugs in the United States, Europe...
    Roivant Sciences Ltd (ROIV)
    Roivant Sciences Ltd (ROIV) is a transformative biopharmaceutical company focused on advancing drug development and commercialization through a distinctive...
    ROIV competitors
    X4 Pharmaceuticals Inc (XFOR)
    X4 Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the research, development...
    XFOR competitors
    Rocket Pharmaceuticals Inc (RCKT)
    Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases.
    RCKT competitors

    Frequently Asked Questions About VRTX

    Who are Vertex Pharmaceuticals' main competitors?

    The companies most similar to Vertex Pharmaceuticals include Regeneron Pharmaceuticals (REGN), Moderna (MRNA), Royalty Pharma Plc (RPRX), BeOne Medicines AG (ONC) and argenx NV ADR (ARGX), listed from the closest match.

    Who is Vertex Pharmaceuticals' biggest competitor?

    Regeneron Pharmaceuticals (REGN) is both the largest of the similar companies at $98.84B and the closest match by business profile, size, sector and industry.

    How does VRTX stock compare with its competitors?

    VRTX's P/E is 30.0x against a peer median of 33.5x; its P/S is 10.5x against a peer median of 16.0x; its net margin is 30.7% against a peer median of 0.0%.

    Which of Vertex Pharmaceuticals' competitors pays a higher dividend?

    Vertex Pharmaceuticals pays no dividend. Royalty Pharma Plc (RPRX) and Regeneron Pharmaceuticals (REGN) have higher forward dividend yields; Royalty Pharma Plc (RPRX) has the highest at 1.37%.

    Is Vertex Pharmaceuticals bigger than its competitors?

    Yes. Vertex Pharmaceuticals is the largest by market cap among the 13 companies on this page, at $136.56B.